Patent classifications
C07C43/18
METHODS FOR THE CONTINUOUS ALKOXYLATION AND DERIVATIZATION OF TERPENES
The invention is directed to methods of producing alkoxylated or hydroxylated terpenes comprising the steps of continuously passing a solution comprising an alcohol in combination with a terpene over an acidic resin catalyst in a packed bed reactor in order to yield a product, as well as compounds that are the products of the methods described herein.
DICYCLOPENTADIENE DERIVATIVES AND POLYMERS THEREOF
Dicyclopentadiene (DCPD) derivatives of following general formula (I); their preparation and use thereof, especially as monomers in polymerization reactions, such as olefin polymerization or ring-opening metathesis polymerization (ROMP).
##STR00001##
SALTS AND SOLID STATE FORMS OF A KIF18A INHIBITOR COMPOUND
Disclosed herein is a salt, a crystalline anhydrous form, a hydrate, a solvate, or a co-crystal of a free base compound 2-(6-azaspiro[2.5]octan-6-yl)-N-[2-(4,4-difluoropiperidin-1-yl)-6-methylpyrimidin-4-yl]-4-[(2-hydroxyethanesulfonyl)amino]benzamide (Compound A); method of preparation, pharmaceutical compositions, and method of treating a disease mediated by a motor protein kinesin family member 18A (KIF18A) inhibition, wherein said disease is a neoplastic disease, including a cancer or a tumor.
SALTS AND SOLID STATE FORMS OF A KIF18A INHIBITOR COMPOUND
Disclosed herein is a salt, a crystalline anhydrous form, a hydrate, a solvate, or a co-crystal of a free base compound 2-(6-azaspiro[2.5]octan-6-yl)-N-[2-(4,4-difluoropiperidin-1-yl)-6-methylpyrimidin-4-yl]-4-[(2-hydroxyethanesulfonyl)amino]benzamide (Compound A); method of preparation, pharmaceutical compositions, and method of treating a disease mediated by a motor protein kinesin family member 18A (KIF18A) inhibition, wherein said disease is a neoplastic disease, including a cancer or a tumor.
Process for the production of 1,4-butanediol and tetrahydrofuran from furan
The present invention provides a process for the preparation of 1,4-butanediol and tetrahydrofuran said process comprising contacting furan with hydrogen and water in the presence of a supported catalytic composition comprising rhenium and palladium in a weight ratio of at least 1:1 and a total combined weight rhenium and palladium in the catalyst composition in the range of from 0.01 to 20 wt %.
Process for the production of 1,4-butanediol and tetrahydrofuran from furan
The present invention provides a process for the preparation of 1,4-butanediol and tetrahydrofuran said process comprising contacting furan with hydrogen and water in the presence of a supported catalytic composition comprising rhenium and palladium in a weight ratio of at least 1:1 and a total combined weight rhenium and palladium in the catalyst composition in the range of from 0.01 to 20 wt %.
INK COMPOSITION FOR ORGANIC LIGHT-EMITTING DEVICE, ORGANIC LIGHT-EMITTING DEVICE INCLUDING FILM FORMED BY USING THE INK COMPOSITION, AND METHOD OF MANUFACTURING THE ORGANIC LIGHT-EMITTING DEVICE
An ink composition for an organic light-emitting device, the ink composition including a luminescent host material and a solvent, wherein the luminescent host material includes at least one compound represented by Formula (1), and wherein the solvent includes at least one selected from an aromatic ether, an aromatic ester, and an aromatic ketone:
##STR00001##
wherein, in Formula (1), groups and variables are the same as described in the specification.
FLUORINE-CONTAINING ETHER COMPOUND, LUBRICANT FOR MAGNETIC RECORDING MEDIUM AND MAGNETIC RECORDING MEDIUM
A fluorine-containing ether compound represented by the following formula: R.sup.1R.sup.2CH.sub.2R.sup.3[CH.sub.2R.sup.4CH.sub.2R.sup.3].sub.xCH.sub.2R.sup.5R.sup.6 (R.sup.1 and R.sup.6 are an organic group having 1 to 50 carbon atoms; R.sup.2 is Formula (2-1) or (2-2); R.sup.5 is Formula (2-3) or (2-4); R.sup.3 is a perfluoropolyether chain; R.sup.4 is Formula (3-1) or (3-2); and x is 0 to 2).
##STR00001##